This inventor holds 1 USPTO granted patent. Top assignee: Sanofi-Synthelabo. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: The Innovations of Xavier Boulenc
Introduction
Xavier Boulenc is a notable inventor based in Montpellier, France. He has made significant contributions to the field of pharmaceuticals, particularly in the formulation of medications. His work focuses on improving the delivery and effectiveness of pharmaceutical compounds.
Latest Patents
Xavier Boulenc holds a patent for "Pharmaceutical formulations in dry form for the oral administration of a cyclic quaternary ammonium compound." This innovative formulation contains from 0.5 to 50% by weight of a cyclic quaternary ammonium compound along with pharmaceutically appropriate excipients. The formulation is created through wet granulation, preferably using polysorbate 80. He has 1 patent to his name.
Career Highlights
Boulenc has had a distinguished career at Sanofi-Synthelabo, a leading global pharmaceutical company. His work has contributed to advancements in drug formulation and delivery systems, enhancing the efficacy of various medications.
Collaborations
Throughout his career, Xavier Boulenc has collaborated with esteemed colleagues such as Bernard Abramovici and Jean-Claude Gautier. These partnerships have fostered innovation and have been instrumental in the development of new pharmaceutical solutions.
Conclusion
Xavier Boulenc's contributions to pharmaceutical formulations demonstrate his commitment to advancing medical science. His innovative work continues to impact the field positively, showcasing the importance of research and development in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile